Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.

Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher A, Ismail MS, Porsteinsson A, Weiner M, Jack CR Jr, Thal L, Aisen PS, Alzheimer's Disease Cooperative Study Group

Open source

DOI: 10.1001/archgenpsychiatry.2011.72
Published: 2011 Aug
Container: Archives of general psychiatry
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/archgenpsychiatry.2011.72,
  title = {Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.},
  author = {Tariot PN and Schneider LS and Cummings J and Thomas RG and Raman R and Jakimovich LJ and Loy R and Bartocci B and Fleisher A and Ismail MS and Porsteinsson A and Weiner M and Jack CR Jr and Thal L and Aisen PS and Alzheimer's Disease Cooperative Study Group},
  year = {2011},
  journal = {Archives of general psychiatry},
  doi = {10.1001/archgenpsychiatry.2011.72},
  url = {https://doi.org/10.1001/archgenpsychiatry.2011.72}
}

RIS

TY  - JOUR
TI  - Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.
AU  - Tariot PN
AU  - Schneider LS
AU  - Cummings J
AU  - Thomas RG
AU  - Raman R
AU  - Jakimovich LJ
AU  - Loy R
AU  - Bartocci B
AU  - Fleisher A
AU  - Ismail MS
AU  - Porsteinsson A
AU  - Weiner M
AU  - Jack CR Jr
AU  - Thal L
AU  - Aisen PS
AU  - Alzheimer's Disease Cooperative Study Group
PY  - 2011
JO  - Archives of general psychiatry
DO  - 10.1001/archgenpsychiatry.2011.72
UR  - https://doi.org/10.1001/archgenpsychiatry.2011.72
ER  -

APA

PN, T., LS, S., J, C., RG, T., R, R., LJ, J., R, L., B, B., A, F., MS, I., A, P., M, W., Jr, J. C., L, T., PS, A., & Group, A. D. C. S. (2011). Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.. Archives of general psychiatry. https://doi.org/10.1001/archgenpsychiatry.2011.72

Source records

pubmed · retrieved 2026-09-25T18:47:17.916Z